Transcat Inc
NASDAQ:TRNS
Intrinsic Value
Transcat, Inc. engages in provision of calibration and laboratory instrument services. [ Read More ]
The intrinsic value of one TRNS stock under the Base Case scenario is 56.35 USD. Compared to the current market price of 109.84 USD, Transcat Inc is Overvalued by 49%.
Valuation Backtest
Transcat Inc
Run backtest to discover the historical profit from buying and selling TRNS stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Transcat Inc
Current Assets | 98.8m |
Cash & Short-Term Investments | 35.2m |
Receivables | 44.1m |
Other Current Assets | 19.5m |
Non-Current Assets | 182.3m |
PP&E | 54.1m |
Intangibles | 127.2m |
Other Non-Current Assets | 1.1m |
Current Liabilities | 29.4m |
Accounts Payable | 11.4m |
Accrued Liabilities | 13.8m |
Other Current Liabilities | 4.2m |
Non-Current Liabilities | 33.3m |
Long-Term Debt | 2.4m |
Other Non-Current Liabilities | 30.8m |
Earnings Waterfall
Transcat Inc
Revenue
|
250.6m
USD
|
Cost of Revenue
|
-171.7m
USD
|
Gross Profit
|
78.9m
USD
|
Operating Expenses
|
-61.8m
USD
|
Operating Income
|
17.1m
USD
|
Other Expenses
|
-6.7m
USD
|
Net Income
|
10.4m
USD
|
Free Cash Flow Analysis
Transcat Inc
TRNS Profitability Score
Profitability Due Diligence
Transcat Inc's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
Score
Transcat Inc's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
TRNS Solvency Score
Solvency Due Diligence
Transcat Inc's solvency score is 82/100. The higher the solvency score, the more solvent the company is.
Score
Transcat Inc's solvency score is 82/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
TRNS Price Targets Summary
Transcat Inc
According to Wall Street analysts, the average 1-year price target for TRNS is 124.64 USD with a low forecast of 120.19 USD and a high forecast of 131.25 USD.
Ownership
TRNS Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
TRNS Price
Transcat Inc
Average Annual Return | 45.88% |
Standard Deviation of Annual Returns | 82.59% |
Max Drawdown | -40% |
Market Capitalization | 969.7m USD |
Shares Outstanding | 8 829 130 |
Percentage of Shares Shorted | 2.48% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Transcat, Inc. engages in provision of calibration and laboratory instrument services. The company is headquartered in Rochester, New York and currently employs 765 full-time employees. Transcat is focused on providing services and products to the life science industry, which includes pharmaceutical, biotechnology, medical device, and other FDA-regulated businesses. Transcat operates through two segments: Service and Distribution. Its Service segment offers calibration, repair, inspection, analytical qualifications, preventative maintenance, consulting, and other related services. Its distribution segment it sells and rent national and brand instruments to customers globally. Its other industries served includes industrial manufacturing; energy and utilities, including oil and gas; chemical manufacturing; FAA-regulated businesses, including aerospace and defense and other industries.
Contact
IPO
Employees
Officers
The intrinsic value of one TRNS stock under the Base Case scenario is 56.35 USD.
Compared to the current market price of 109.84 USD, Transcat Inc is Overvalued by 49%.